[Prospects for using hydroxyethyl starch in the complex of intensive care during interhospital transportation of critically ill patients with polytrauma]

Anesteziol Reanimatol. 2009 Sep-Oct:(5):77-9.
[Article in Russian]

Abstract

The paper analyzes the results of a comparative study of different infusion therapy modalities in victims with polytrauma during transportation to a specialized traumatological center. A combination of crystalloids and dextrans was applied to a control group and hydroxyethyl starch (HES) 130/0.4 was used in a study group. The evaluation criteria were the maintenance of stable hemodynamic parameters during transportation; a negative effect on hemostatic parameters and a preventive effect against the development of multiple organ dysfunction during transportation. Infusion therapy using HES has an advantage by all the parameters estimated.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Critical Care / methods*
  • Critical Care / standards
  • Crystalloid Solutions
  • Dextrans / administration & dosage
  • Dextrans / adverse effects
  • Dextrans / therapeutic use
  • Fluid Therapy / methods*
  • Fluid Therapy / standards
  • Hemodynamics / drug effects
  • Humans
  • Hydroxyethyl Starch Derivatives / administration & dosage*
  • Hydroxyethyl Starch Derivatives / adverse effects
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Isotonic Solutions / administration & dosage
  • Isotonic Solutions / therapeutic use
  • Middle Aged
  • Multiple Trauma / therapy*
  • Plasma Substitutes / administration & dosage*
  • Plasma Substitutes / adverse effects
  • Plasma Substitutes / therapeutic use
  • Transportation of Patients / methods*
  • Transportation of Patients / standards
  • Treatment Outcome
  • Young Adult

Substances

  • Crystalloid Solutions
  • Dextrans
  • HES 130-0.4
  • Hydroxyethyl Starch Derivatives
  • Isotonic Solutions
  • Plasma Substitutes